# Encompass Health Corporation (EHC): Analyst Ratings Signal 19.61% Upside Potential

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-ehc-analyst-ratings-signal-19-61-upside-potential/4121208414
- Published: 2025-07-21T10:21:46+01:00
- Author: Madison Wilson

Encompass Health Corporation (NYSE: EHC) stands out within the healthcare sector,
particularly in the medical care facilities industry. With its roots dating back
to 1984 under the name HealthSouth Corporation, the company has since evolved, rebranding
as Encompass Health Corporation in 2018. Based in Birmingham, Alabama, EHC provides
essential post-acute healthcare services across the United States and Puerto Rico,
specializing in inpatient rehabilitation for conditions like strokes and hip fractures.

Currently trading at $110.01, EHC’s share price has seen fluctuations within a 52-
week range of $84.68 to $122.63. Despite a slight price dip of $0.35 recently, the
company’s stock is garnering significant attention from investors due to its promising
growth metrics and analyst ratings.

One of the most compelling reasons to consider EHC is its robust revenue growth,
reported at 10.60%. This reflects the company’s effective strategies in expanding
its market presence and enhancing service offerings. Additionally, with an EPS of
4.86 and a remarkable return on equity of 24.58%, Encompass Health demonstrates 
its ability to generate substantial profits relative to shareholder equity.

The company’s valuation metrics paint an interesting picture. While traditional 
P/E and PEG ratios are unavailable, the forward P/E stands at 19.70, indicating 
market optimism about future earnings. EHC’s financial performance is further bolstered
by a free cash flow of $235.85 million, providing flexibility for strategic investments
and dividends.

Dividend-seeking investors might find EHC’s yield of 0.55% modest, yet the low payout
ratio of 13.58% suggests potential for future dividend increases as the company 
continues to grow its earnings.

Perhaps most intriguing is the consensus among analysts regarding EHC’s stock. All
13 analysts covering the stock have issued a “Buy” rating, with no holds or sells.
The average target price is $131.58, marking a potential upside of 19.61% from the
current price level, with target estimates ranging between $125.00 and $140.00.

From a technical perspective, the stock’s recent movements suggest a potential buying
opportunity. The 50-day moving average of $118.92 and the 200-day moving average
of $104.13 indicate recent price volatility. The Relative Strength Index (RSI) of
48.45 signals a neutral stance, yet the negative MACD of -2.18 compared to the signal
line of -0.93 might warrant cautious optimism.

Overall, Encompass Health Corporation presents a compelling case for investors seeking
exposure in the healthcare sector. Its strong revenue growth, solid financial performance,
and unanimous buy ratings from analysts offer a promising outlook. As the company
continues to expand its footprint and capitalize on its core strengths, investors
should keep a close eye on EHC’s potential trajectory in the coming quarters.

Share on: